Eisai Establishes a New Subsidiary in China for Marketing Support and Maintenance of Pharmaceutical Manufacturing Machinery
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that Eisai Machinery Co., Ltd. (Headquarters: Tokyo, President: Kenji Hanawa, “EMC”), a wholly-owned subsidiary of Eisai, has established Eisai Machinery Shanghai Inc. (“EMS”), a new subsidiary in China which provides marketing support and maintenance services for pharmaceutical production machines.
EMS will be committed to marketing Automatic Inspection Machine (“AIM”) for particulate inspection of ampoules and vials, developed by Eisai, in rapidly growing Chinese market through promoting on-site sales supports and after-sales maintenance services to be offered by local employees hired in China.
Eisai started distribution of AIMs in 1975, and currently, through the establishment of EMC in 2004, more than 880 machines were installed in major pharmaceutical manufacturers in over 50 countries worldwide. EMC has its overseas marketing hub for AIMs in the U.S. and Germany.
Through its wholly-owned subsidiary in China, Eisai has been manufacturing and marketing its global pharmaceutical products including Aricept®, an Alzheimer's disease treatment, Pariet®, a proton pump inhibitor, and Methycobal®, a peripheral neuropathy treatment. With the establishment of EMS, Eisai further continues to make contributions to providing of high-quality pharmaceutical products in China.
Corporate Communications Department
Eisai Co., Ltd.